A Missing Lipid Tag on PDZK1 Emerges as a Hidden Cause of Sluggish Sperm

Male infertility often hides in plain sight. For a substantial share of affected couples, the sperm are present and apparently normal in shape and number, yet they simply do not swim well enough to reach and fertilize an egg. This condition, known as asthenozoospermia, is one of the leading causes of male infertility worldwide, and its molecular roots have remained frustratingly obscure. Now, a team of researchers working at institutions in Guangzhou, Shenzhen, Yangling and Wuhan in China has traced a surprising thread through the biology of sperm maturation, one that begins not in the testis but in the epididymis, the coiled duct through which every sperm must pass before it can move with purpose. Their study, published as an open-access original article in Cellular and Molecular Life Sciences, points to a specific chemical modification of a protein called PDZK1 as a linchpin of sperm motility.

The modification in question is palmitoylation, the attachment of a fatty acid chain, palmitate, to a protein. Palmitoylation is a reversible lipid tag that anchors otherwise soluble proteins to cell membranes, and it is carried out by a family of enzymes known as ZDHHC palmitoyltransferases. When the research team, led by corresponding author Weibing Qin of the NHC Key Laboratory of Male Reproduction and Genetics at the Guangdong Provincial Reproductive Science Institute, compared sperm from asthenozoospermic patients with sperm from healthy donors, they found two striking deficits. Both the overall abundance of PDZK1 protein and the extent of its palmitoylation were significantly reduced in the sluggish sperm. In other words, the problem was not merely that less PDZK1 was present, but that the remaining protein lacked the fatty anchor it needs to do its job.

To understand why that anchor matters, it helps to know what happens to sperm as they leave the testis. Newly formed sperm are essentially immotile and must acquire the capacity for forward movement during their transit through the epididymis. Along the way, they are bathed in a dynamic environment and receive cargo from small membrane vesicles called epididymosomes, which are shed by the epithelial cells lining the duct. These vesicles deliver proteins and lipids that remodel the sperm surface, and among the cargo is PDZK1. One of the critical cargo functions concerns cholesterol. During epididymal maturation, sperm membranes must lose a portion of their cholesterol to become properly fluid and flexible; if cholesterol efflux is dysregulated, the membrane stiffens and the sperm cannot generate the coordinated flagellar beating required for progressive motility.

The researchers assembled a three-pronged body of evidence to connect PDZK1 palmitoylation to this process. First, they analyzed clinical samples from asthenozoospermic men and healthy controls, confirming the dual loss of PDZK1 protein and palmitoylation in the patient group. Second, they turned to a mouse model in which palmitoylation was chemically inhibited with 2-bromopalmitate, a widely used inhibitor of palmitoyltransferases. When mice were treated with this compound, the animals recapitulated the asthenozoospermic phenotype: their sperm showed impaired motility, and PDZK1 was specifically depleted from both the sperm themselves and from the epididymosomes that normally ferry the protein to the sperm surface. Third, the team used in vitro approaches to dissect the biochemistry of the interaction, allowing them to identify precisely which part of the protein carries the lipid tag and which enzyme attaches it.

That dissection yielded a remarkably specific answer. The critical palmitoylation site on PDZK1 is cysteine 10, abbreviated C10, a single amino acid near the very beginning of the protein. The enzyme responsible for attaching palmitate to this site was identified as ZDHHC5. When cysteine 10 is palmitoylated, PDZK1 gains the membrane anchor it needs to localize to membranes, to be incorporated into epididymosomes, and to interact with SR-BI, a scavenger receptor class B type I protein that is a well-known player in cellular cholesterol traffic. Without the lipid tag, PDZK1 fails to reach the membranes, fails to board the epididymosomal transport system, and fails to engage SR-BI, and the downstream consequence is a breakdown of cholesterol homeostasis in the sperm membrane.

The functional outcome of that breakdown is cholesterol accumulation in the sperm membrane, the very opposite of the controlled cholesterol efflux that maturation demands. Excess membrane cholesterol reduces membrane fluidity and disrupts the lipid organization that flagellar movement depends upon, providing a coherent mechanistic explanation for why the sperm of affected patients move poorly. The chain of causation therefore runs from a single modified cysteine, through a palmitoyltransferase, into the epididymosomal cargo system, and out to the physical properties of the sperm membrane. It is a vivid illustration of how a seemingly minor chemical decoration on one protein can govern a trait as macroscopic as whether a cell can swim.

Perhaps the most clinically provocative part of the study is what happened when the researchers tried to reverse the damage. When palmitic acid, the fatty acid substrate of palmitoylation, was supplied to the system within an optimal dose range, sperm motility improved. Even more strikingly, the administration of epididymosomes enriched with palmitoylated PDZK1 also improved sperm motility. These rescue experiments do more than confirm the mechanism; they suggest that the pathway is not a one-way street. If the defect is a shortage of properly palmitoylated PDZK1 reaching the sperm, then replenishing that supply, either by supporting the palmitoylation reaction itself or by delivering pre-palmitoylated PDZK1 via epididymosome-like vesicles, may restore function.

The authors are careful to frame these findings as a foundation for future therapeutic development rather than an immediate treatment. Asthenozoospermia is a heterogeneous condition with many contributing causes, and the new work identifies one specific molecular lesion within that landscape. Still, the identification of PDZK1 palmitoylation as a mechanistic target opens concrete possibilities. Diagnostic assays could one day measure PDZK1 abundance or palmitoylation status in sperm samples to stratify patients whose infertility stems from this pathway. Interventions might range from nutritional or pharmacological support of ZDHHC5-mediated palmitoylation to engineered epididymosome preparations that deliver functional PDZK1 to sperm. The optimal dose range noted for palmitic acid supplementation also underscores that any such approach would require careful titration, since fatty acid biology is dose-sensitive and excess lipid can create problems of its own.

The study also adds to a broader scientific appreciation of palmitoylation as a master regulator of reproductive biology. Because the modification is reversible and enzyme-driven, it offers cells a rapid, tunable way to control where proteins reside, and the epididymis appears to exploit this flexibility extensively during the assembly of a functional sperm surface. By pinpointing ZDHHC5 as the relevant transferase and cysteine 10 as the relevant site, the researchers have converted a diffuse correlation, low PDZK1 in poor sperm, into a precise, testable molecular circuit. The work was supported by funding from the Postdoctoral Research Project of Guangdong Provincial Fertility Hospital, the Natural Science Foundation of Guangdong Province, the Medical Research Foundation of Guangdong Province, the Shenzhen Science and Technology Program, and the National Natural Science Foundation of China, and it was conducted with ethics approval and written informed consent from all participants.

For the millions of couples affected by unexplained male infertility, the significance of this research lies in its reframing of the problem. A defect in swimming, it turns out, can originate in a fat molecule attached to a single cysteine in a scaffolding protein, in a duct the sperm passes through days before it is ever asked to swim. The epididymal maturation program, long appreciated as essential but poorly understood at the molecular level, is now yielding its secrets, and cholesterol transport via epididymosomes has moved to the center of the picture. Whether PDZK1 palmitoylation becomes a routine clinical marker or the basis of a new therapy, the study demonstrates that the route from basic lipid biochemistry to human fertility can be remarkably short, and that some of the most important instructions a sperm ever receives are written in grease.

Subject of Research: Defective PDZK1 palmitoylation and its role in epididymosome-mediated cholesterol transport and asthenozoospermia

Article Title: Defective PDZK1 palmitoylation impairs epididymosome-mediated cholesterol transport and contributes to asthenozoospermia

Article References: Cao, H., Liu, S., Li, X., Liu, X., Wu, F., Nie, H., Zhu, S., Zhou, Y., Ma, C., Li, L., Gao, H., Dong, Q., Qu, M., Liu, H., Dong, W., & Qin, W. (2026). Defective PDZK1 palmitoylation impairs epididymosome-mediated cholesterol transport and contributes to asthenozoospermia. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06464-y

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06464-y

Keywords: PDZK1, palmitoylation, ZDHHC5, epididymosomes, cholesterol homeostasis, asthenozoospermia, male infertility, sperm motility, SR-BI, epididymal maturation, lipid modification, membrane trafficking